IT Management, ERP, M and A integration and Business Transformation Consultant @ Striatum Technology Consultants (April 2018 - Present)
Vice President Information Technology @ Karuna Therapeutics - acquired by Bristol Myers Squibb (July 2023 - May 2025)
Vice President Information Technology @ Albireo Pharma, Inc. - acquired by IPSEN BIOSCIENCE (December 2022 - June 2023)
Vice President Information Technology @ (October 2021 - December 2022)
Vice President Information Technology @ Epizyme - acquired by IPSEN BIOSCIENCE (March 2019 - October 2021)
Head of Enterprise Management and Technology Transfer (CIO equivalent) @ (January 2008 - April 2018)
Sr. Director, Global Program Management and Business Optimization @ (January 2008 - January 2018)
AVP, International Operations and Business Development @ (January 2008 - December 2018)
Owner and Principal Business Application and SAP Consultant @ Strategic Alliance Group, Inc (January 1998 - December 2008)
International Sr. Business System Analysts and MIS Manager and SW dev @ (January 1992 - December 1998)
Design and Software Engineer @ (January 1988 - December 1992)
Michael Catarina Education
Bryant University
MBA (International Business)
University of Rhode Island
BS (Computer Electrical Engineering)
Michael Catarina Summary
Michael Catarina, based in Cambridge, MA, US, is currently a Chief Technology Officer at Organogenesis. Michael Catarina brings experience from previous roles at Striatum Technology Consultants, Karuna Therapeutics - acquired by Bristol Myers Squibb, Albireo Pharma, Inc. - acquired by IPSEN BIOSCIENCE and Repertoire Immune Medicines. Michael Catarina holds a MBA in International Business @ Bryant University. Michael Catarina has 2 emails and 1 mobile phone numbers on RocketReach.
Looking for a different Michael Catarina?
Find contact details for 700 million professionals.